Drawing for MK2

USPTO serial 79339182

MK2

Reviewed by CopyMark Law Group

Reg. 7403919Status 700Registered
Filing date
Status date
Registration date
Jun 4, 2024
Examiner
BEGGS, MONICA L
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MK2?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Donna J. Bunton

Donna J. Bunton NIXON & VANDERHYE P.C.901 North Glebe Road, 11th FloorArlington, VA 22203UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Media for cell culture for use in the biotechnological industry, enzymes derived from biotechnological processes for use in industry; peptides for industrial purposes, peptide substrates for scientific purposes; amino acids for scientific purposes, amino acids for industrial purposes, biotechnologically-formed genes for use in the manufacture of agricultural seeds, polymers for use in the analysis of biochemicals, thickening agents being biochemical products for industrial use; biochemicals, namely, polypeptides for in vitro research use; biochemicals, namely, precursors for in vitro genetic engineering use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; biochemical catalysts, catalysts for use in biochemical processes, biochemical precursors for scientific purposes, biochemical preparations for scientific purposes, biochemical reagents other than for medical use, biochemical substances for scientific or research use, catalysts for chemical and biochemical processes, biochemical reagents used for non-medical purposes, enzymes for use as biochemical catalystsACTIVE—
002Bactericidal paints, bactericidal coatings in the nature of paints, bactericidal paints and washes in the nature of paints, dust proofing chemical preparations in the nature of paints; colorants for use in the manufacture of cosmetics; pigments for use in the manufacture of pharmaceuticals; colorants for use in the manufacture of pharmaceuticals; exterior surface protective coatings for preventing staining; chemical proof paints; coatings in the nature of industrial sealants for waterproofing; fluorescent paints; coloured fluorescent paints in powder form; fluorescent brightening agent dyes; binding preparations for paints; wood preservatives; based preservatives against deterioration of wood; preservative coatings for paper and wood surfaces; fungicidal coatings in the nature of paintsACTIVE—
003Laundry washing preparations, non-medicated mouth washes; adhesives for cosmetic purposesACTIVE—
005Chemical test reagents for medical purposes, diagnostic preparations for medical purposes; amino acids for medical purposes, amino acids for veterinary purposes, bactericides, biological tissue cultures for medical purposes; bacteriological preparations for medical purposes, diagnostic preparations for medical or veterinary purposes, cell growth media for growing cells for medical use, medical diagnostic reagents and assays for testing of body fluids; biological indicators for monitoring sterilization processes for medical or veterinary purposesACTIVE—
042Research relating to biotechnology, biotechnology product testing, biochemistry services in the nature of custom design and development of biochemical assays, biochemical engineering services, biochemical analysis, air flow biochemical analysis services, biochemistry research services, biochemistry research and analysis, chemical research and analysis services, scientific research and development, biological research and analysis, biological development services, scientific laboratory servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 7, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 16, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 15, 2024FIMPFINAL DISPOSITION PROCESSED—
Sep 4, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 4, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 4, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 18, 2024ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Mar 11, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 5, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 5, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 4, 2024GPNXNOTIFICATION PROCESSED BY IB—
Feb 21, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 21, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 14, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 14, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 14, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 14, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 25, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 18, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 17, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 17, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 10, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Aug 10, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 10, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 10, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 13, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 13, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 13, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 7, 2023RFNTREFUSAL PROCESSED BY IB—
Jan 17, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 17, 2023RFRRREFUSAL PROCESSED BY MPU—
Nov 16, 2022ATRVATTORNEY REVIEW COMPLETED—
Nov 15, 2022CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED—
Nov 4, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 3, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2022DOCKASSIGNED TO EXAMINER—
Sep 11, 2022CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
May 3, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 29, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 28, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance